The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period…
The COVID-19 pandemic had a negative impact on the US biosurgical agent market. However, recovery of the deferred procedures and procedure volume growth will drive modest growth in the market over…
The European biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, increasing procedure volume along with rising awareness of the clinical benefits of biosurgical…
Procedure deferrals due to the COVID-19 pandemic severely impacted the European biosurgical agent market in 2020, and the elective nature of many postponed procedures will hinder the pace of…
The COVID-19 pandemic has negatively impacted the Asia Pacific biosurgical agent market due to the deferral or cancelation of elective and semi-elective procedures; however, following a period of…
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by…
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by…
Although it will be impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Japan will grow at a moderate rate through 2029, driven by rising surgical procedure…